How to start clinical research as an ancillary in gastroenterology

Praveen Suthrum, President of NextServices interviews Dr. Narayanachar Murali (South Carolina), Dr. Don Lazas (ObjectiveGI, Tennessee) and Dr. Chris Fourment (CRSG and Precision Research, Texas). Learn how to start clinical research as an ancillary.

****

Read the full transcript of this interview here - nextservices.com/how-to-start-clinical-trials-r…

****

SCOPE FORWARD - Releasing on 26th August, 2020.
Visit our website now: scope-forward.com/

****

In this interview, you’ll learn three different perspectives on clinical trials/research as an ancillary in a GI practice. We’ll explore the pros/cons, costs, risks, and operating models.

Consider this interview as a primer on starting up with clinical trials/research. In the coming weeks, we’ll release more detailed interviews on the topic.

Key Insights:

◘ How Dr. Murali got started with clinical trials 25 years ago (1:46)
◘ Complexity has increased (3:21)
◘ Trials help you stay ahead of the game (5:27)
◘ Advice for starting clinical trials (6:28)
◘ Know your operational costs (8:56)
◘ Risks involved (9:52)
◘ Why ObjectiveGI? (10:38)
◘ Integrated with GI workflow (13:00)
◘ The future is chronic disease management (13:37)
◘ “We now have 14 sites, 25 NASH trials and 150 providers” (14:06)
◘ Clinical research is a foundation for other ancillaries (14:46)
◘ A traditional joint venture model (15:18)
◘ Expenses to consider (15:34)
◘ Investment is less than $100k (17:49)
◘ Clinical Research Strategy Group/Precision Research (21:22)
◘ CRSG helps sites build research (21:48)
◘ Precision Research is a consortium of successful research sites (22:29)
◘ Fourment’s background (23:12)
◘ “What is ideal in my mind is an average patient visit generating $1,700 to $1,800 per visit” (26:11)
◘ Profitability in Clinical Research (27:25)
◘ Clinical Trials Management System (27:57)
◘ Establishing a budget (29:34)
◘ Playing the role of a co-director (30:09)
◘ Costs to consider (30:26)

****

Please Like, Share and Subscribe to our channel to never miss out on such thought-provoking interviews.

****

#clinicaltrials #ObjectiveGI #gastroenterology #CRSG #IBD #NASH #NAFLD #liverdiseases #hepatology #scopeforward #solopractice #risks #healthcare #medicine #ancillaries #pharmaceuticals #trials #research